{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:57:15Z","timestamp":1791205035924,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jormas.2026.102944","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:10:15Z","timestamp":1786637415000},"page":"102944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune checkpoint inhibitors in the management of oral mucosal melanoma"],"prefix":"10.1016","volume":"127","author":[{"given":"Niko","family":"Paavilainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Degerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Salo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-4939","authenticated-orcid":false,"given":"Matti","family":"Mauramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jormas.2026.102944_bib0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jcms.2025.01.012","article-title":"Clinical patterns and outcomes of patients affected by primary malignant melanoma of the oral mucosa: a European multicenter retrospective chart review","volume":"53","author":"Boffano","year":"2025","journal-title":"J Craniomaxillofac Surg"},{"issue":"3","key":"10.1016\/j.jormas.2026.102944_bib0002","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/odi.14647","article-title":"Tongue metastasis of malignant melanoma: a case report and a systemic review of the literature","volume":"30","author":"S\u00e4\u00e4ksj\u00e4rvi","year":"2023","journal-title":"Oral Dis"},{"key":"10.1016\/j.jormas.2026.102944_bib0003","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","article-title":"Mucosal melanoma of the head and neck","volume":"112","author":"Ascierto","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.jormas.2026.102944_bib0004","doi-asserted-by":"crossref","DOI":"10.1111\/pcmr.70017","article-title":"Oral melanoma in older adults: epidemiology, molecular landscape, and treatment strategies","volume":"38","author":"de Arruda","year":"2025","journal-title":"Pigment Cell Melanoma Res"},{"issue":"20","key":"10.1016\/j.jormas.2026.102944_bib0005","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jormas.2026.102944_bib0006","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/j.jormas.2022.02.002","article-title":"Oral mucosal melanoma\u2014a systematic review","volume":"123","author":"Thuaire","year":"2022","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"32","key":"10.1016\/j.jormas.2026.102944_bib0007","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jormas.2026.102944_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jormas.2026.102944_bib0009","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jormas.2026.102944_bib0010","series-title":"JBI manual for evidence synthesis","article-title":"Chapter 7: systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"key":"10.1016\/j.jormas.2026.102944_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107267","article-title":"Efficacy of pembrolizumab monotherapy for advanced gingival malignant melanoma: a case report","volume":"164","author":"Li","year":"2025","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.jormas.2026.102944_bib0022","article-title":"Challenges in the diagnosis and treatment of oral amelanotic malignant melanoma: a case report","volume":"16","author":"Rosu","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jormas.2026.102944_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.890546","article-title":"Case report: good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma","volume":"13","author":"Pan","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jormas.2026.102944_bib0024","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ajoms.2022.03.006","article-title":"A case of melanoma of the mandibular gingiva with long-term survival: effect of nivolumab therapy and immuno-radiotherapy for cervical recurrence and nasal metastasis","volume":"34","author":"Kitabatake","year":"2022","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"issue":"1","key":"10.1016\/j.jormas.2026.102944_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3892\/mco.2021.2435","article-title":"Role of debulking surgery in combination with immune therapy: a successfully treated case of locally advanced mucosal melanoma","volume":"16","author":"Kimura","year":"2022","journal-title":"Mol Clin Oncol"},{"issue":"10","key":"10.1016\/j.jormas.2026.102944_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001219","article-title":"Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission","volume":"9","author":"Satish","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.jormas.2026.102944_bib0026","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13256-020-02541-3","article-title":"Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report","volume":"14","author":"Onishi","year":"2020","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jormas.2026.102944_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104919","article-title":"Abscopal effect of radiation therapy after nivolumab monotherapy in a patient with oral mucosal melanoma: a case report","volume":"108","author":"Igarashi","year":"2020","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.jormas.2026.102944_bib0017","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/CJI.0000000000000282","article-title":"Combination nivolumab\/ipilimumab immunotherapy for melanoma with subsequent unexpected cardiac arrest: a case report and review of literature","volume":"42","author":"Khoury","year":"2019","journal-title":"J Immunother"},{"issue":"1","key":"10.1016\/j.jormas.2026.102944_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1346-8138.14041","article-title":"Synergistic effects of interferon-beta and nivolumab in oral mucosal melanoma","volume":"45","author":"Fusumae","year":"2018","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jormas.2026.102944_bib0019","article-title":"Abscopal effect in a stage IV melanoma patient who progressed on pembrolizumab","volume":"10","author":"Tsui","year":"2018","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jormas.2026.102944_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1902\/cap.2016.160003","article-title":"Primary oral melanoma - a non-surgical approach to treatment via immunotherapy","volume":"7","author":"Casta\u00f1o","year":"2017","journal-title":"Clin Adv Periodontics"},{"issue":"10","key":"10.1016\/j.jormas.2026.102944_bib0030","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/jdv.13336","article-title":"Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma","volume":"30","author":"Kato","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jormas.2026.102944_bib0031","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamadermatol.2015.0249","article-title":"Occurrence of psoriasiform eruption during nivolumab therapy for primary oral mucosal melanoma","volume":"151","author":"Ohtsuka","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jormas.2026.102944_bib0011","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00432-022-04090-2","article-title":"Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma","volume":"149","author":"Wu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jormas.2026.102944_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/odi.70206","article-title":"Pembrolizumab with anlotinib in advanced oral mucosal melanoma: a retrospective trial","author":"Bi","year":"2026","journal-title":"Oral Dis"},{"issue":"3","key":"10.1016\/j.jormas.2026.102944_bib0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/cco-23-16","article-title":"Epidemiology, staging and management of mucosal melanoma of the head and neck: a narrative review","volume":"12","author":"Jeong","year":"2023","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.jormas.2026.102944_bib0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jormas.2026.102944_bib0018","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/SCS.0000000000008054","article-title":"Oral mucosal melanoma","volume":"33","author":"Nisi","year":"2022","journal-title":"J Craniofacial Surg"},{"key":"10.1016\/j.jormas.2026.102944_bib0020","article-title":"Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update","volume":"25","author":"Lipson","year":"2025","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.jormas.2026.102944_bib0021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785526002405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785526002405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:43:54Z","timestamp":1791204234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785526002405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2468785526002405"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2026.102944","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint inhibitors in the management of oral mucosal melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2026.102944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102944"}}